India’s API market, valued at US$14.2 billion in 2025, is racing ahead at 8.5% CAGR, and 3 pharma stocks are quietly powering this global surge.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback